A multicenter comparison of MOG-IgG cell-based assays

A multicenter comparison of MOG-IgG cell-based assays

<p><strong>Objectives</strong> To compares 3 different myelin oligodendrocyte glycoprotein–immunoglobulin G (IgG) cell-based assays (CBAs) from 3 international centers.</p> <p><strong>Methods</strong> Serum samples from 394 patients were as follows: acute di...

Full description

Bibliographic Details
Main Authors:	Waters, P, Komorowski, L, Woodhall, M, Lederer, S, Majed, M, Fryer, J, Mills, J, Flanagan, E, Irani, S, Kunchok, A, McKeon, A, Pittock, S
Format:	Journal article
Published:	American Academy of Neurology 2019

Similar Items

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
by: Waters, P, et al.
Published: (2012)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
by: Pace, S, et al.
Published: (2021)

MOG-IgG1 antibodies in children
by: Waters, P, et al.
Published: (2018)

International multicenter examination of MOG antibody assays
by: Reindl, M, et al.
Published: (2020)

Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases
by: Kim, Y, et al.
Published: (2020)

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
by: Hyun, J, et al.
Published: (2018)

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
by: Whittam, DH, et al.
Published: (2020)

IgG4-related disease
by: Culver, EL, et al.
Published: (2019)

Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease
by: Hamid, S, et al.
Published: (2017)

A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG)
by: Waters, P, et al.
Published: (2007)

MOG-IGG IN NMO AND NMO-LIKE DISORDERS
by: Luppe, S, et al.
Published: (2014)

Deteksi IgG
by: , SUHARTI, Netti, et al.
Published: (2001)

IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease
by: Motta, RV, et al.
Published: (2024)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
by: Jarius, S, et al.
Published: (2007)

Pain and the immune system: Emerging concepts of IgG-mediated autoimmune pain and immunotherapies
by: Xu, M, et al.
Published: (2018)

Comparison of IgG-ELISA and IgG4-ELISA for Toxocara serodiagnosis
by: Noordin, R., et al.
Published: (2005)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
by: Littleton, E, et al.
Published: (2006)

Phenotypic differences between IgG4 + and IgG 1 + B cells point to distinct regulation of the IgG 4 response
by: Lighaam, L, et al.
Published: (2014)

Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response.
by: Lighaam, L, et al.
Published: (2014)

Transient IgA, steady IgG?
by: Berthold, DL, et al.
Published: (2020)

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG
by: Huda, S, et al.
Published: (2017)

An international multicentre validation experiment for MOG antibodies
by: Reindl, M, et al.
Published: (2018)

Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research
by: Low, Swee Ling, et al.
Published: (2021)

Lymphoplasmacytic lymphoma with paraprotein IgG
by: Mat Yusuf, Shaidatina, et al.
Published: (2022)

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG–positive NMOSD
by: Shosha, E, et al.
Published: (2018)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters
by: Koneczny, I, et al.
Published: (2013)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
by: Koneczny, I, et al.
Published: (2013)

GABAA receptor autoimmunity: a multicenter experience
by: O'Connor, K, et al.
Published: (2019)

Selection of diagnostic cutoffs for murine typhus IgM and IgG immunofluorescence assay: a systematic review
by: Dhawan, S, et al.
Published: (2020)

MOG-IgA as a potential marker of germinal center activity
by: Handel, AE, et al.
Published: (2024)

Specific IgG subclass antibodies, IgE and IgG S-TS antibodies to wheat gluten fraction B in patients with coeliac disease.
by: Rawcliffe, P, et al.
Published: (1985)

Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)
by: Lee, S, et al.
Published: (2024)

IgG4-related sclerosing cholangitis
by: Culver, E, et al.
Published: (2017)

NMO-IgG in the diagnosis of neuromyelitis optica.
by: Jarius, S, et al.
Published: (2007)

Structural biology of IgG Fc glycoforms
by: Baruah, K
Published: (2012)

Impact of COVID-19 infection and vaccination in pancreatobiliary IgG4-related disease patients: an international multicenter study
by: Tang, Raymond S. Y., et al.
Published: (2023)

High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.
by: Pucić, M, et al.
Published: (2011)

High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations
by: Pučić, M, et al.
Published: (2011)

Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
by: Niks, E, et al.
Published: (2008)

High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.
by: Pucić, M, et al.
Published: (2011)